Results 81 to 90 of about 9,359 (237)

Emulating a Randomized Controlled Trial of Long‐Acting Insulins and Cardiovascular Events Using Real‐World Data for Patients With Type 2 Diabetes

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 1, January 2026.
ABSTRACT Aims Randomized controlled trials (RCTs) have high internal validity but often have limited generalizability. To our knowledge, there have been no previous studies emulating RCTs using real‐world data to evaluate the risk of major adverse cardiovascular events (MACE) among patients with type 2 diabetes mellitus (T2DM) treated with long‐acting ...
Wanning Wang, Pauline Reynier, Michael Webster‐Clark, Oriana H. Y. Yu, Vanessa Brunetti, Kristian B. Filion   +5 more
wiley   +1 more source

Enhanced Radionuclide Therapy via the Conjugation of Pentadecanoic Acids With 225Ac‐ and 177Lu‐Labeled RGD Peptides

Cancer Science, Volume 117, Issue 1, Page 193-202, January 2026.
Radionuclide therapy using PD‐K(225Ac‐DOTA)‐RGD in BxPC‐3‐bearing mice. PD‐K(225Ac‐DOTA)‐RGD successfully suppressed tumor growth. ABSTRACT Improved peptide pharmacokinetics are needed to enhance the therapeutic effects of peptide‐based radionuclide therapy.
Mitsuyoshi Yoshimoto, Shun‐ichi Wada, Yukie Yoshii, Sayaka Hanadate, Anri Inaki, Hirofumi Fujii   +5 more
wiley   +1 more source

Initiation of Hybrid Closed‐Loop Artificial Pancreas System Improves Glycemic Control in a Hospitalized Type 1 Diabetes: A Case Report and Review

Case Reports in Endocrinology, Volume 2026, Issue 1, 2026.
Background To observe the efficacy and safety of artificial pancreas (Android‐hybrid closed‐loop [HCL] system) in patients with type 1 diabetes mellitus (T1DM), and to compare it with insulin multi‐injection therapy. Case presentation A patient with long course of type 1 diabetes was treated with multiple injections of insulin, Android‐HCL therapy, and
Shaohua Li, Pin Lv, Haosi Lu, Yang Liu, Yang Shen, Cijing Cai, Xifeng Zeng, Hongyun Lu, Yu Zhao, Kalyani Sen   +9 more
wiley   +1 more source

South Asian Consensus Guideline: Use of insulin in diabetes during Ramadan

Indian Journal of Endocrinology and Metabolism, 2012
A person with diabetes mellitus (DM) has every right to perform the ritual of fasting during Ramadan. In daily practice we come across both type 1 and type 2 DM who wish to fast.
Md Faruque Pathan, Rakesh Kumar Sahay, Abdul Hamid Zargar, Syed Abbas Raza, A K Azad Khan, Mohammed Ashraf Ganie, Nazrul Islam Siddiqui, Firoz Amin, Osama Ishtiaq, Sanjay Kalra   +9 more
doaj   +1 more source

Análisis de costo-efectividad del uso de Detemir en pacientes con diabetes tipo 2 en riesgo de presentar eventos cardiovasculares y muerte en Colombia

Salud Uninorte, 2014
Objetivo: Analizar la costo-efectividad del uso de Detemir frente a otras insulinas (Glargine e NPH) para tratamiento de diabetes tipo 2 en Colombia. Métodos: Mediante un modelo de Markov se analizó la costo-efectividad desde la perspectiva del tercero ...
Martín Romero Prada, Nelson Alvis Guzmán, Diana Chávez Bejarano, Elizabeth Karpf Benavides   +3 more
doaj  

Comparison of a Multiple Daily Insulin Injection Regimen (Glargine or Detemir Once Daily Plus Prandial Insulin Aspart) and Continuous Subcutaneous Insulin Infusion (Aspart) in Short-Term Intensive Insulin Therapy for Poorly Controlled Type 2 Diabetes Patients

International Journal of Endocrinology, 2013
Aims. To examine the potential differences between multiple daily injection (MDI) regimens based on new long-acting insulin analogues (glargine or detemir) plus prandial insulin aspart and continuous subcutaneous insulin aspart infusion (CSII) in ...
Wen-shan Lv, Li Li, Jun-ping Wen, Rong-fang Pan, Rui-xia Sun, Jing Wang, Yu-xin Xian, Cai-xia Cao, Yan-yan Gao   +8 more
doaj   +1 more source

Forum for injection techniques, India: The first Indian recommendations for best practice in insulin injection technique

Indian Journal of Endocrinology and Metabolism, 2012
Advances in the treatment of diabetes have led to an increase in the number of injectable therapies, such as human insulin, insulin analogues, and glucagon-like peptide-1 analogues.
Sanjay Kalra, Yatan Pal Singh Balhara, Manash P Baruah, Manoj Chadha, Hemraj B Chandalia, Subhankar Chowdhury, K M Prasanna Kumar, Sonal Modi, Shailesh Pitale, Rishi Shukla, Rakesh Sahay, Annamalai Sundaram, Ambika G Unnikrishnan, Subhash K Wangnoo   +13 more
doaj   +1 more source

Cost analysis of insulin degludec in comparison with insulin detemir in treatment of children and adolescents with type 1 diabetes in the UK

BMJ Open Diabetes Research & Care, 2019
Objective With healthcare systems under increasing financial pressure from costs associated with diabetes care, it is important to assess which treatments provide clinical benefits and represent best value.
N. Thalange, J. Gundgaard, W. Parekh, D. Tutkunkardas   +3 more
semanticscholar   +1 more source

Management of feline diabetes mellitus: update and challenges [PDF]

, 2017
PòsterJun
Caparrós Vallcorba, Cristina, Universitat Autònoma de Barcelona. Facultat de Veterinària   +1 more
core